West Pharmaceutical Services Inc (WST)

Current ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total current assets US$ in thousands 1,936,400 1,972,300 1,874,200 1,937,200 1,919,500 1,733,600 1,771,100 1,690,500 1,742,000 1,598,300 1,477,000 1,327,000 1,373,700 1,238,300 1,110,600 977,500 1,058,700 1,004,100 944,300 867,600
Total current liabilities US$ in thousands 671,800 533,500 511,600 534,900 519,000 456,700 565,100 584,800 594,100 558,600 472,600 482,800 503,400 447,700 375,200 344,400 341,600 335,000 313,200 301,100
Current ratio 2.88 3.70 3.66 3.62 3.70 3.80 3.13 2.89 2.93 2.86 3.13 2.75 2.73 2.77 2.96 2.84 3.10 3.00 3.02 2.88

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $1,936,400K ÷ $671,800K
= 2.88

The current ratio of West Pharmaceutical Services, Inc. has shown fluctuations over the past eight quarters, ranging from 2.88 to 3.80. In Q4 2023, the current ratio was 2.88, indicating that the company's current assets were 2.88 times its current liabilities. This was lower compared to the previous quarter, Q3 2023, where the current ratio was 3.70.

The company experienced a decrease in its current ratio in Q4 2023, which may raise concerns about its short-term liquidity position. A current ratio below 3.00 may suggest that the company could face challenges in meeting its short-term obligations. It will be important for West Pharmaceutical Services, Inc. to closely monitor its liquidity management and working capital to ensure it can cover its short-term liabilities in a sustainable manner.


Peer comparison

Dec 31, 2023

Company name
Symbol
Current ratio
West Pharmaceutical Services Inc
WST
2.88
Carlisle Companies Incorporated
CSL
2.87